Chordia Therapeutics Inc. (JP:190A) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Chordia Therapeutics Inc., a Japanese biotech firm, was honored with the Minister of Education, Culture, Sports, Science and Technology Award at the Japan Startup Awards 2024 for its innovative work in cancer therapy commercialization. The company, a university spin-out, has developed new anti-cancer drugs with significant financial milestones and royalties linked to future sales. Chordia’s efforts contribute to the drug discovery ecosystem and provide new treatment options for cancer patients.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.